log in
Print | Back

Walder Wyss Ltd.

Alexander Gutmans

Alexander Gutmans

Partner

Expertise

  • Corporate & Commercial
  • Corporate Finance & Capital Markets
  • Healthcare & Life Science
  • Healthcare & Life Sciences

WSG Practice Industries

Activity

Walder Wyss Ltd.
Switzerland

WSG Leadership

Corporate & Commercial
Co-Chair
Corporate Finance & Capital Markets
Co-Chair
Healthcare & Life Sciences
Co-Chair
Industry & Commerce
Co-Chair
Mergers & Acquisitions
Co-Chair
Notary
Co-Chair
Private Equity & Venture Capital
Co-Chair
Real Estate & Construction
Co-Chair
Life Sciences Group
Member
Profile
Alexander Gutmans is a partner at Walder Wyss since 2014. He advises national and international clients in the fields of commercial and corporate law, mergers & acquisitions, private equity, venture capital and financings as well as in the field of health care and life sciences in contractual and regulatory matters. As a notary of the canton Basel-Stadt he accompanies his clients in commercial register and real estate register transactions as well as German notarisations. Alexander Gutmans is also active as board member.

Born in 1967, Alexander Gutmans studied at the university of Basel (lic. iur. 1990; Dr. iur. 1995) and Lausanne an received a master’s degree from Yale Law School (LL.M. 1996). In 1993 Alexander Gutmans was admitted as attorney at law and in 2002 as notary. He started his professional career as legal counsel at Sandoz AG and after an assignment as foreign associate with an American law firm in New York he worked during 15 years as a lawyer for a leading Swiss law firm with offices in Basel, Bern and Zurich, during the last 11 years as a partner.

Alexander Gutmans‘ professional work languages are German and English. He also speaks French.
Areas of Practice

Corporate & Commercial | Corporate Finance & Capital Markets | Healthcare & Life Science | Healthcare & Life Sciences | Industry & Commerce | Mergers & Acquisitions | Notary | Private Equity & Venture Capital | Real Estate | Real Estate & Construction

Professional Career

Significant Accomplishments


Alentis Therapeutics erhält USD 67 Mio. im Rahmen einer Serie-B-Finanzierung

proLogistik Holding GmbH erwirbt XELOG AG

Calibre Scientific, Inc. acquires HUBERLAB.AG

Boehringer Ingelheim kauft NBE-Therapeutics für EUR 1,18 Milliarden

Noema Pharma Serie A-Finanzierungsrunde über CHF 54 Mio.

Synendos Therapeutics CHF 20m Series A Financing

VectivBio USD 110m Crossover Financing

Monte Rosa Therapeutics Serie B-Finanzierungsrunde über USD 96 Mio.

BioVersys Serie B-Finanzierungsrunde über CHF 19 Mio.

Versant Ventures lanciert Matterhorn Biosciences

Versant Ventures bringt Bright Peak Therapeutics auf den Markt

Walder Wyss berät BC Platforms im Hinblick auf die Series C Finanzierung über USD 15 Millionen sowie eine Partnerschaft mit IQVIA zum Ausbau der Datenanalytik im Bereich Genomik

ImmunOs Therapeutics AG raises CHF 15m in Series A Financing

Lindsay Goldberg übernimmt Bilcare Research Group

Boehringer Ingelheim erwirbt Amal Therapeutics SA

2020 Best Lawyers Awards

Seed Financing Round bei Premark Pharma GmbH

CHF 12.5 Million Finanzierungsrunde bei Alentis Therapeutics AG

Precision Surfacing Solutions kauft Wafer Geschäft von Meyer Burger

SHS investiert in Schweizer Life-Science-Unternehmen evitria AG

Cellestia Biotech AG: CHF 20 Millionen Series A Finanzierungsrunde

TOLREMO Therapeutics AG CHF 9 Mio. Serie A Finanzierungsrunde

Nouscom AG EUR 42 Mio. Serie B Finanzierungsrunde

BC Platforms CHF10 Mio. B Runde

BioVersys CHF 5.5 Mio. Serie A Runde

RWS acquires LUZ, Inc.

Acino veräussert sein Geschäft mit transdermalen Pflastern an Luye Pharma Group Ltd.

Bayer verkauft Diabetes-Care-Geschäft

Bayer und CRISPR Therapeutics gründen Genome Editing Joint Venture

Honeywell übernimmt Aviaso

Finanzierungsrunde von CRISPR Therapeutics

Avanade erwirbt KCS.net

P&I Personal & Informatik AG übernimmt Geschäftsbereich HR der Soreco AG

SVC-AG für KMU Risikokapital erwirbt Minderheitsbeteiligung an Stratpharma AG


Articles


§ 35 Einführung in die Grundlagen und die Systematik des schweizerischen Medizinprodukterechts


WSG's members are independent firms and are not affiliated in the joint practice of professional services. Each member exercises its own individual judgments on all client matters.

HOME | SITE MAP | GLANCE | PRIVACY POLICY | DISCLAIMER |  © World Services Group, 2021